Endocrine disruptors, gene deregulation and male germ cell tumors

International Journal of Developmental Biology

Volumn 57, Issue 2-4, 2013, Pages 225-239

  Del Mazo, Jesús ^a   Brieño Enríquez, Miguel A ^a   García López, Jesús ^a   López Fernández, Luis A ^b   De Felici, Massimo ^c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

DNA methylation; Epigenetic; Histone modification; MiRNA; PiRNA; Primordial germ cell; Testis; Tumor

Indexed keywords

ENDOCRINE DISRUPTOR; MESSENGER RNA; SMALL UNTRANSLATED RNA;

ARTICLE; CELL DIFFERENTIATION; DEVELOPMENT; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; EPIGENETICS; GENE CONTROL; GENE DEREGULATION; GENE EXPRESSION; GENE REGULATORY NETWORK; GERM CELL TUMOR; GONAD DEVELOPMENT; GONAD FUNCTION; HOMEOSTASIS; HORMONAL REGULATION; HUMAN; MOLECULAR GENETICS; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; TESTIS CANCER; TESTIS DEVELOPMENT; TESTIS TUMOR; TRANSCRIPTOMICS;

ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS;

EID: 84880065742     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.130042jd     Document Type: Article

References (264)

1. ADAMS, B.D., FURNEAUX, H. and WHITE, B.A. (2007). The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 21: 1132-1147.
2. ALBERS, P., ALBRECHT, W., ALGABA, F., BOKEMEYER, C., COHN-CEDERMARK, G., FIZAZI, K., HORWICH, A. and LAGUNA, M.P. (2011). EAU guidelines on testicular cancer: 2011 update. Eur Urol 60: 304-319.
3. ALMSTRUP, K., HOEI-HANSEN, C.E., WIRKNER, U., BLAKE, J., SCHWAGER, C., ANSORGE, W., NIELSEN, J.E., SKAKKEBAEK, N.E., RAJPERTDE MEYTS, E. and LEFFERS, H. (2004). Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64: 4736-4743.
4. AMBROS, V. (2001). microRNAs: tiny regulators with great potential. Cell 107: 823-826.
5. ANDERSON, A.M., CARTER, K.W., ANDERSON, D. and WISE, M.J. (2012). Co-expression of nuclear receptors and histone methylation modifying genes in the testis: implications for endocrine disruptor modes of action. PLoS ONE 7: e34158.
6. ANWAY, M.D., CUPP, A.S., UZUMCU, M. and SKINNER, M.K. (2005). Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308: 1466-1469.
7. ANWAY, M.D., LEATHERS, C. and SKINNER, M.K. (2006). Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocri-nology 147: 5515-5523.
8. ARAVIN, A., GAIDATZIS, D., PFEFFER, S., LAGOS-QUINTANA, M., LANDGRAF, P., IOVINO, N., MORRIS, P., BROWNSTEIN, M.J., KURAMOCHI-MIYAGAWA, S., NAKANO, T. et al., (2006). A novel class of small RNAs bind to MILI protein in mouse testes. Nature 442: 203-207.
9. ASKLUND, C., JORGENSEN, N., KOLD JENSEN, T. and SKAKKEBAEK, N.E. (2004). Biology and epidemiology of testicular dysgenesis syndrome. BJU Int 93 Suppl 3: 6-11.
10. AVISSAR-WHITING, M., VEIGA, K.R., UHL, K.M., MACCANI, M.A., GAGNE, L.A., MOEN, E.L. and MARSIT, C.J. (2010). Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 29: 401-406.
11. BANNISTER, A.J. and KOUZARIDES, T. (2011). Regulation of chromatin by histone modifications. Cell Res 21: 381-395.
12. BENTWICH, I. (2005). Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910.
13. BENTWICH, I., AVNIEL, A., KAROV, Y., AHARONOV, R., GILAD, S., BARAD, O., BARZILAI, A., EINAT, P., EINAV, U., MEIRI, E. et al., (2005). Identification of hun-dreds of conserved and nonconserved human microRNAs. Nat Genet 37: 766-770.
14. BIRD, A., TAGGART, M., FROMMER, M., MILLER, O.J. and MACLEOD, D. (1985). A fraction of the mouse genome that is derived from islands of nonmethylated, CpG-rich DNA. Cell 40: 91-99.
15. BIRD, A.P. and WOLFFE, A.P. (1999). Methylation-induced repression--belts, braces, and chromatin. Cell 99: 451-454.
16. BLOW, M.J., GROCOCK, R.J., VAN DONGEN, S., ENRIGHT, A.J., DICKS, E., FUTREAL, P.A., WOOSTER, R. and STRATTON, M.R. (2006). RNA editing of human microRNAs. Genome Biol 7: R27.
17. BORGEL, J., GUIBERT, S., LI, Y., CHIBA, H., SCHUBELER, D., SASAKI, H., FORNE, T. and WEBER, M. (2010). Targets and dynamics of promoter DNA methylation during early mouse development. Nat Genet 42: 1093-1100.
18. BRASE, J.C., WUTTIG, D., KUNER, R. and SULTMANN, H. (2010). Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer 9: 306.
19. BREHM, A., OVITT, C.E. and SCHOLER, H.R. (1998). Oct-4: more than just a POUerful marker of the mammalian germline? APMISA 106: 114-24; discussion 124-126.
20. BRENNAN, J. and CAPEL, B. (2004). One tissue, two fates: molecular genetic events that underlie testis versus ovary development. Nat Rev Genet 5: 509-521.
21. BROMER, J.G., ZHOU, Y., TAYLOR, M.B., DOHERTY, L. and TAYLOR, H.S. (2010). Bisphenol-A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 24: 2273-2280.
22. CALIN, G.A. and CROCE, C.M. (2006). MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-66.
23. CAO, C., PAYNE, K., LEE-KWON, W., ZHANG, Z., LIM, S.W., HAMLYN, J., BLAUS-TEIN, M.P., KWON, H.M. and PALLONE, T.L. (2009). Chronic ouabain treatment induces vasa recta endothelial dysfunction in the rat. Am J Physiol Renal Physiol 296: F98-F106.
24. CARLSEN, E., GIWERCMAN, A., KEIDING, N. and SKAKKEBAEK, N.E. (1992). Evidence for decreasing quality of semen during past 50 years. BMJ 305: 609-613.
25. CASTELLANO, L., GIAMAS, G., JACOB, J., COOMBES, R.C., LUCCHESI, W., THIRUCHELVAM, P., BARTON, G., JIAO, L.R., WAIT, R., WAXMAN, J. et al., (2009). The estrogen receptor-alpha-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci USA 106: 15732-15737.
26. CLEMENT, T.M., SAVENKOVA, M.I., SETTLES, M., ANWAY, M.D. and SKINNER, M.K. (2010). Alterations in the developing testis transcriptome following embryonic vinclozolin exposure. Reprod Toxicol 30: 353-364.
27. COLBORN, T. and CLEMENT, C. (1992). Chemically induced alterations in sexual development: the wildlife/human connection. Princeton Scientific Publishing, Princeton (NJ).
28. COOK, M.S., MUNGER, S.C., NADEAU, J.H. and CAPEL, B. (2011). Regulation of male germ cell cycle arrest and differentiation by DND1 is modulated by genetic background. Development 138: 23-32.
29. COSTA, F.F. (2008). Non-coding RNAs, epigenetics and complexity. Gene 410: 9-17.
30. CROSS, S.H. and BIRD, A.P. (1995). CpG islands and genes. Curr Opin Genet Dev 5: 309-314.
31. CUPP, A.S., UZUMCU, M., SUZUKI, H., DIRKS, K., PHILLIPS, B. and SKINNER, M.K. (2003). Effect of transient embryonic in vivo exposure to the endocrine disruptor methoxychlor on embryonic and postnatal testis development. J Androl 24: 736-745.
32. CHANDLER, K.J., BARRIER, M., JEFFAY, S., NICHOLS, H.P., KLEINSTREUER, N.C., SINGH, A.V., REIF, D.M., SIPES, N.S., JUDSON, R.S., DIX, D.J. et al., (2011). Evaluation of 309 environmental chemicals using a mouse embryonic stem cell adherent cell differentiation and cytotoxicity assay. PLoS ONE 6: e18540.
33. CHANG, T.C., ZEITELS, L.R., HWANG, H.W., CHIVUKULA, R.R., WENTZEL, E.A., DEWS, M., JUNG, J., GAO, P., DANG, C.V., BEER, M.A. et al., (2009). Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation. Proc Natl Acad Sci USA 106: 3384-3389.
34. CHEN, A.X., YU, K.D., FAN, L., LI, J.Y., YANG, C., HUANG, A.J. and SHAO, Z.M. (2011). Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet 7: e1002259.
35. CHIA, V.M., LI, Y., QURAISHI, S.M., GRAUBARD, B.I., FIGUEROA, J.D., WEBER, J.P., CHANOCK, S.J., RUBERTONE, M.V., ERICKSON, R.L. and MCGLYNN, K.A. (2010). Effect modification of endocrine disruptors and testicular germ cell tumour risk by hormone-metabolizing genes. Int J Androl 33: 588-596.
36. CHIOSEA, S., JELEZCOVA, E., CHANDRAN, U., ACQUAFONDATA, M., MCHALE, T., SOBOL, R.W. and DHIR, R. (2006). Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol 169: 1812-1820.
37. CHOI, J.S., OH, J.H., PARK, H.J., CHOI, M.S., PARK, S.M., KANG, S.J., OH, M.J., KIM, S.J., HWANG, S.Y. and YOON, S. (2011). miRNA regulation of cytotoxic ef-fects in mouse Sertoli cells exposed to nonylphenol. Reprod Biol Endocrinol 9: 126.
38. CHUA, J.H., ARMUGAM, A. and JEYASEELAN, K. (2009). MicroRNAs: biogenesis, function and applications. Curr Opin Mol Ther 11: 189-199.
39. CHUANG, J.C. and JONES, P.A. (2007). Epigenetics and microRNAs. Pediatr Res 61: 24R-29R.
40. DE CARVALHO, D.D., YOU, J.S. and JONES, P.A. (2010). DNA methylation and cellular reprogramming. Trends Cell Biol 20: 609-617.
41. DE FELICI, M. (2001). Twenty years of research on primordial germ cells. Int J Dev Biol 45: 519-522.
42. DE FELICI, M. (2009). Primordial germ cell biology at the beginning of the XXI century. Int J Dev Biol 53: 891-894.
43. DE FELICI, M. (2011). Nuclear reprogramming in mouse primordial germ cells: epigenetic contribution. Stem Cells Int 2011: 425863.
44. DE FELICI, M. (2012). Origin, migration and proliferation of human primordial germ cells. In Oogenesis, (ed. GOTICCHIO, G.). Springer-Verlag, London.
45. DE FELICI, M. and FARINI, D. (2012). The control of cell cycle in mouse primordial germ cells: old and new players. Curr Pharm Des 18: 233-244.
46. DE JONG, J., STOOP, H., DOHLE, G.R., BANGMA, C.H., KLIFFEN, M., VAN ESSER, J.W., VAN DEN BENT, M., KROS, J.M., OOSTERHUIS, J.W. and LOOIJENGA, L.H. (2005). Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 206: 242-249.
47. DE LUIS, O. and DEL MAZO, J. (1998). Gene expression of mouse M1 and M2 pyruvate kinase isoenzymes correlates with differential poly[A] tract extension of their mRNAs during the development of spermatogenesis. Biochim Biophys Acta 1396: 294-305.
48. DEDES, K.J., NATRAJAN, R., LAMBROS, M.B., GEYER, F.C., LOPEZ-GARCIA, M.A., SAVAGE, K., JONES, R.L. and REIS-FILHO, J.S. (2011). Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer. Eur J Cancer 47: 138-150.
49. DOLINOY, D.C., DAS, R., WEIDMAN, J.R. and JIRTLE, R.L. (2007a). Metastable epial-leles, imprinting, and the fetal origins of adult diseases. Pediatr Res 61: 30R-37R.
50. DOLINOY, D.C., HUANG, D. and JIRTLE, R.L. (2007b). Maternal nutrient supplementa-tion counteracts bisphenol A-induced DNA hypomethylation in early development. Proc Natl Acad Sci USA 104: 13056-13061.
51. DONOVAN, P.J. (1994). Growth factor regulation of mouse primordial germ cell development. Curr Top Dev Biol 29: 189-225.
52. DONOVAN, P.J. and DE MIGUEL, M.P. (2003). Turning germ cells into stem cells. Curr Opin Genet Dev 13: 463-471.
53. EDWARDS, T.M. and MYERS, J.P. (2007). Environmental exposures and gene regula-tion in disease etiology. Environ Health Perspect 115: 1264-1270.
54. ESTELLER, M. (2007). Cancer epigenomics: DNA methylomes and histone-modifi-cation maps. Nat Rev Genet 8: 286-298.
55. FABBRI, M. (2008). MicroRNAs and cancer epigenetics. Curr Opin Investig Drugs 9: 583-590.
56. FEIL, R. and FRAGA, M.F. (2012). Epigenetics and the environment: emerging pat-terns and implications. Nat Rev Genet 13: 97-109.
57. FICOCIELLO, B., STURCHIO, E., MINOIA, C., CASORRI, L., IMBRIANI, P. and SIGNORINI, S. (2010). [Epigenetics and environmental exposure to xenobiotics]. G Ital Med Lav Ergon 32: 13-22.
58. FRAGA, M.F., BALLESTAR, E., PAZ, M.F., ROPERO, S., SETIEN, F., BALLESTAR, M.L., HEINE-SUNER, D., CIGUDOSA, J.C., URIOSTE, M., BENITEZ, J. et al., (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102: 10604-10609.
59. FRANCOIS, E., WANG, D.Y., FULTHORPE, R., LISS, S.N. and EDWARDS, E.A. (2003). DNA microarrays for detecting endocrine-disrupting compounds. Bio-technol Adv 22: 17-26.
60. GARCIA-LOPEZ, J. and DEL MAZO, J. (2012). Expression dynamics of microRNA biogenesis during preimplantation mouse development. Biochim Biophys Acta 1819: 847-854.
61. GASHAW, I., DUSHAJ, O., BEHR, R., BIERMANN, K., BREHM, R., RUBBEN, H., GROBHOLZ, R., SCHMID, K.W., BERGMANN, M. and WINTERHAGER, E. (2007). Novel germ cell markers characterize testicular seminoma and fetal testis. Mol Hum Reprod 13: 721-727.
62. GASHAW, I., GRUMMER, R., KLEIN-HITPASS, L., DUSHAJ, O., BERGMANN, M., BREHM, R., GROBHOLZ, R., KLIESCH, S., NEUVIANS, T.P., SCHMID, K.W. et al., (2005). Gene signatures of testicular seminoma with emphasis on expression of ets variant gene 4. Cell Mol Life Sci 62: 2359-2368.
63. GERSON, S.L. (2004). MGMT: its role in cancer aetiology and cancer therapeutics. Nat Rev Cancer 4: 296-307.
64. GIBSON, G. (2008). The environmental contribution to gene expression profiles. Nat Rev Genet 9: 575-581.
65. GIDEKEL, S. and BERGMAN, Y. (2002). A unique developmental pattern of Oct-3/4 DNA methylation is controlled by a cis-demodification element. J Biol Chem 277: 34521-34530.
66. GIDEKEL, S., PIZOV, G., BERGMAN, Y. and PIKARSKY, E. (2003). Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4: 361-370.
67. GIGLIO, M., MEDICA, M., DE ROSE, A.F., GERMINALE, F., RAVETTI, J.L. and CARMIGNANI, G. (2003). Testicular sertoli cell tumours and relative sub-types. Analysis of clinical and prognostic features. Urol Int 70: 205-210.
68. GILAD, S., MEIRI, E., YOGEV, Y., BENJAMIN, S., LEBANONY, D., YERUSHALMI, N., BENJAMIN, H., KUSHNIR, M., CHOLAKH, H., MELAMED, N. et al., (2008). Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
69. GILBERT, D., RAPLEY, E. and SHIPLEY, J. (2011). Testicular germ cell tumours: predisposition genes and the male germ cell niche. Nat Rev Cancer 11: 278-288.
70. GILLIS, A.J., STOOP, H., BIERMANN, K., VAN GURP, R.J., SWARTZMAN, E., CRIBBES, S., FERLINZ, A., SHANNON, M., OOSTERHUIS, J.W. and LOOI-JENGA, L.H. (2011). Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int J Androl 34: e160-e174.
71. GILLIS, A.J., STOOP, H.J., HERSMUS, R., OOSTERHUIS, J.W., SUN, Y., CHEN, C., GUENTHER, S., SHERLOCK, J., VELTMAN, I., BAETEN, J. et al., (2007). High-throughput microRNAome analysis in human germ cell tumours. J Pathol 213: 319-28.
72. GIRARD, A., SACHIDANANDAM, R., HANNON, G.J. and CARMELL, M.A. (2006). A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature 442: 199-202.
73. GODIN, I., DEED, R., COOKE, J., ZSEBO, K., DEXTER, M. and WYLIE, C.C. (1991). Effects of the steel gene product on mouse primordial germ cells in culture. Nature 352: 807-809.
74. GONZALEZ-GONZALEZ, E., LOPEZ-CASAS, P.P. and DEL MAZO, J. (2008). The expression patterns of genes involved in the RNAi pathways are tissue-dependent and differ in the germ and somatic cells of mouse testis. Biochim Biophys Acta 1779: 306-311.
75. GREENE, M.H., KRATZ, C.P., MAI, P.L., MUELLER, C., PETERS, J.A., BRATSLAVSKY, G., LING, A., CHOYKE, P.M., PREMKUMAR, A., BRACCI, J. et al., (2010). Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype. Endocr Relat Cancer 17: R109-R121.
76. GREER, E.L. and SHI, Y. (2012). Histone methylation: a dynamic mark in health, disease and inheritance. Nat Rev Genet 13: 343-357.
77. GRELIER, G., VOIRIN, N., AY, A.S., COX, D.G., CHABAUD, S., TREILLEUX, I., LEON-GODDARD, S., RIMOKH, R., MIKAELIAN, I., VENOUX, C. et al., (2009). Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype. Br J Cancer 101: 673-683.
78. GRIVNA, S.T., BEYRET, E., WANG, Z. and LIN, H. (2006). A novel class of small RNAs in mouse spermatogenic cells. Genes Dev 20: 1709-1714.
79. GUARNIERI, D.J. and DILEONE, R.J. (2008). MicroRNAs: a new class of gene regulators. Ann Med 40: 197-208.
80. HACKETT, J.A., ZYLICZ, J.J. and SURANI, M.A. (2012). Parallel mechanisms of epigenetic reprogramming in the germline. Trends Genet 28: 164-174.
81. HAGAN, J.P., PISKOUNOVA, E. and GREGORY, R.I. (2009). Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat Struct Mol Biol 16: 1021-1025.
82. HART, A.H., HARTLEY, L., PARKER, K., IBRAHIM, M., LOOIJENGA, L.H., PAUCHNIK, M., CHOW, C.W. and ROBB, L. (2005). The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104: 2092-2098.
83. HAYASHI, K., CHUVA DE SOUSA LOPES, S.M., KANEDA, M., TANG, F., HAJKOVA, P., LAO, K., O'CARROLL, D., DAS, P.P., TARAKHOVSKY, A., MISKA, E.A. et al., (2008). MicroRNA biogenesis is required for mouse primordial germ cell develop-ment and spermatogenesis. PLoS ONE 3: e1738.
84. HE, Z., KOKKINAKI, M., PANT, D., GALLICANO, G.I. and DYM, M. (2009). Small RNA molecules in the regulation of spermatogenesis. Reproduction 137: 901-911.
85. HEIJMANS, B.T., TOBI, E.W., LUMEY, L.H. and SLAGBOOM, P.E. (2009). The epig-enome: archive of the prenatal environment. Epigenetics 4: 526-531.
86. HEO, I., JOO, C., CHO, J., HA, M., HAN, J. and KIM, V.N. (2008). Lin28 mediates the terminal uridylation of let-7 precursor MicroRNA. Mol Cell 32: 276-284.
87. HO, S.M., TANG, W.Y., BELMONTE DE FRAUSTO, J. and PRINS, G.S. (2006). Developmental exposure to estradiol and bisphenol A increases susceptibility toprostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66: 5624-5632.
88. HOEI-HANSEN, C.E., ALMSTRUP, K., NIELSEN, J.E., BRASK SONNE, S., GRAEM, N., SKAKKEBAEK, N.E., LEFFERS, H. and RAJPERT-DE MEYTS, E. (2005). Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 47: 48-56.
89. HONECKER, F., STOOP, H., DE KRIJGER, R.R., CHRIS LAU, Y.F., BOKEMEYER, C. and LOOIJENGA, L.H. (2004). Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 203: 849-857.
90. HONORIO, S., AGATHANGGELOU, A., WERNERT, N., ROTHE, M., MAHER, E.R. and LATIF, F. (2003). Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of semi-noma and nonseminoma testicular germ cell tumours. Oncogene 22: 461-466.
91. HOU, L., WANG, D. and BACCARELLI, A. (2011). Environmental chemicals and microRNAs. Mutat Res 714: 105-112.
92. HOU, L., ZHANG, X., WANG, D. and BACCARELLI, A. (2012). Environmental chemical exposures and human epigenetics. Int J Epidemiol 41: 79-105.
93. HOULDSWORTH, J., KORKOLA, J.E., BOSL, G.J. and CHAGANTI, R.S. (2006). Biology and genetics of adult male germ cell tumors. J Clin Oncol 24: 5512-5518.
94. HUANG, Q., GUMIREDDY, K., SCHRIER, M., LE SAGE, C., NAGEL, R., NAIR, S., EGAN, D.A., LI, A., HUANG, G., KLEIN-SZANTO, A.J. et al., (2008). The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210.
95. HUDDER, A. and NOVAK, R.F. (2008). miRNAs: effectors of environmental influences on gene expression and disease. Toxicol Sci 103: 228-240.
96. HUSSAIN, S.A., MA, Y.T., PALMER, D.H., HUTTON, P. and CULLEN, M.H. (2008). Biology of testicular germ cell tumors. Expert Rev Anticancer Ther 8: 1659-1673.
97. HUSTIN, J., COLLETTE, J. and FRANCHIMONT, P. (1987). Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl 10: 29-35.
98. HUYGHE, E., MATSUDA, T. and THONNEAU, P. (2003). Increasing incidence of testicular cancer worldwide: a review. J Urol 170: 5-11.
99. IGUCHI, T., WATANABE, H. and KATSU, Y. (2006). Application of ecotoxicogenomics for studying endocrine disruption in vertebrates and invertebrates. Environ Health Perspect 114 Suppl 1: 101-105.
100. IGUCHI, T., WATANABE, H. and KATSU, Y. (2007). Toxicogenomics and eco-toxicogenomics for studying endocrine disruption and basic biology. Gen Comp Endocrinol 153: 25-29.
101. IONA, S., KLINGER, F.G., SISTI, R., CICCALESE, R., NUNZIATA, A. and DE FELICI, M. (2002). A comparative study of cytotoxic effects of N-ethyl-N-nitrosourea, adriamycin, and mono-(2-ethylhexyl)phthalate on mouse primordial germ cells. Cell Biol Toxicol 18: 131-145.
102. IZZOTTI, A., CALIN, G.A., ARRIGO, P., STEELE, V.E., CROCE, C.M. and DE FLORA, S. (2009a). Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23: 806-812.
103. IZZOTTI, A., CALIN, G.A., STEELE, V.E., CROCE, C.M. and DE FLORA, S. (2009b). Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J 23: 3243-3250.
104. JENUWEIN, T. and ALLIS, C.D. (2001). Translating the histone code. Science 293: 1074-1080.
105. JIANG, L.I. and NADEAU, J.H. (2001). 129/Sv mice--a model system for studying germ cell biology and testicular cancer. Mamm Genome 12: 89-94.
106. JOHNSON, S.M., GROSSHANS, H., SHINGARA, J., BYROM, M., JARVIS, R., CHENG, A., LABOURIER, E., REINERT, K.L., BROWN, D. and SLACK, F.J. (2005). RAS is regulated by the let-7 microRNA family. Cell 120: 635-647.
107. JORDAN, I.K., ROGOZIN, I.B., GLAZKO, G.V. and KOONIN, E.V. (2003). Origin of a substantial fraction of human regulatory sequences from transposable elements. Trends Genet 19: 68-72.
108. JUNG, S.M., CHU, P.H., SHIU, T.F., WU, H.H., KUO, T.T., CHU, J.J. and LIN, P.J. (2006). Expression of OCT4 in the primary germ cell tumors and thymoma in the mediastinum. Appl Immunohistochem Mol Morphol 14: 273-275.
109. KAZAZIAN, H.H., JR. (2004). Mobile elements: drivers of genome evolution. Science 303: 1626-1632.
110. KEDDE, M., STRASSER, M.J., BOLDAJIPOUR, B., OUDE VRIELINK, J.A., SLANCHEV, K., LE SAGE, C., NAGEL, R., VOORHOEVE, P.M., VAN DUIJSE, J., OROM, U.A. et al., (2007). RNA-binding protein Dnd1 inhibits microRNA access to target mRNA. Cell 131: 1273-1286.
111. KEEGAN, L.P., GALLO, A. and O'CONNELL, M.A. (2001). The many roles of an RNA editor. Nat Rev Genet 2: 869-878.
112. KELCE, W.R., MONOSSON, E., GAMCSIK, M.P., LAWS, S.C. and GRAY, L.E., JR. (1994). Environmental hormone disruptors: evidence that vinclozolin developmen-tal toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 126: 276-285.
113. KEMPKENSTEFFEN, C., CHRISTOPH, F., WEIKERT, S., KRAUSE, H., KOLLER-MANN, J., SCHOSTAK, M., MILLER, K. and SCHRADER, M. (2006). Epigenetic silencing of the putative tumor suppressor gene testisin in testicular germ cell tumors. J Cancer Res Clin Oncol 132: 765-770.
114. KIM, J.K., SAMARANAYAKE, M. and PRADHAN, S. (2009). Epigenetic mechanisms in mammals. Cell Mol Life Sci 66: 596-612.
115. KIM, V.N. (2006). Small RNAs just got bigger: Piwi-interacting RNAs (piRNAs) in mammalian testes. Genes Dev 20: 1993-1997.
116. KIMBLE, J. and PAGE, D.C. (2007). The mysteries of sexual identity. The germ cell's perspective. Science 316: 400-401.
117. KIMURA, T., SUZUKI, A., FUJITA, Y., YOMOGIDA, K., LOMELI, H., ASADA, N., IKEUCHI, M., NAGY, A., MAK, T.W. and NAKANO, T. (2003). Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130: 1691-1700.
118. KRISTENSEN, D.M., SONNE, S.B., OTTESEN, A.M., PERRETT, R.M., NIELSEN, J.E., ALMSTRUP, K., SKAKKEBAEK, N.E., LEFFERS, H. and RAJPERT-DE MEYTS, E. (2008). Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. Mol Cell Endocrinol 288: 111-118.
119. KUBICEK, S., SCHOTTA, G., LACHNER, M., SENGUPTA, R., KOHLMAIER, A., PEREZ-BURGOS, L., LINDERSON, Y., MARTENS, J.H., O'SULLIVAN, R.J., FODOR, B.D. et al., (2006). The role of histone modifications in epigenetic tran-sitions during normal and perturbed development. Ernst Schering Res Found Workshop1-27.
120. LA SALA, G., FARINI, D. and DE FELICI, M. (2009). Proapoptotic effects of lindane on mouse primordial germ cells. Toxicol Sci 108: 445-451.
121. LA SALA, G., FARINI, D. and DE FELICI, M. (2010). Rapid estrogen signalling in mouse primordial germ cells. Exp Cell Res 316: 1716-1727.
122. LADOMERY, M.R., MADDOCKS, D.G. and WILSON, I.D. (2011). MicroRNAs: their discovery, biogenesis, function and potential use as biomarkers in non-invasive prenatal diagnostics. Int J Mol Epidemiol Genet 2: 253-260.
123. LAU, P.W. and MACRAE, I.J. (2009). The molecular machines that mediate microRNA maturation. J Cell Mol Med 13: 54-60.
124. LEE, Y.S. and DUTTA, A. (2007). The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030.
125. LESSARD, C., PENDOLA, J.K., HARTFORD, S.A., SCHIMENTI, J.C., HANDEL, M.A. and EPPIG, J.J. (2004). New mouse genetic models for human contraceptive development. Cytogenet Genome Res 105: 222-227.
126. LEWIS, B.P., BURGE, C.B. and BARTEL, D.P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
127. LI, S., HURSTING, S.D., DAVIS, B.J., MCLACHLAN, J.A. and BARRETT, J.C. (2003). Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. Ann N Y Acad Sci 983: 161-169.
128. LOOIJENGA, L.H., GILLIS, A.J., STOOP, H., HERSMUS, R. and OOSTERHUIS, J.W. (2007a). Relevance of microRNAs in normal and malignant development, including human testicular germ cell tumours. Int J Androl 30: 304-314; discussion 314-315.
129. LOOIJENGA, L.H., GILLIS, A.J., STOOP, H.J., HERSMUS, R. and OOSTERHUIS, J.W. (2007b). Chromosomes and expression in human testicular germ-cell tumors: insight into their cell of origin and pathogenesis. Ann N Y Acad Sci 1120: 187-214.
130. LOOIJENGA, L.H., STOOP, H., DE LEEUW, H.P., DE GOUVEIA BRAZAO, C.A., GILLIS, A.J., VAN ROOZENDAAL, K.E., VAN ZOELEN, E.J., WEBER, R.F., WOLFFENBUTTEL, K.P., VAN DEKKEN, H. et al., (2003a). POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63: 2244-2250.
131. LOOIJENGA, L.H., ZAFARANA, G., GRYGALEWICZ, B., SUMMERSGILL, B., DEBIEC-RYCHTER, M., VELTMAN, J., SCHOENMAKERS, E.F., RODRIGUEZ, S., JAFER, O., CLARK, J. et al., (2003b). Role of gain of 12p in germ cell tumour development. APMIS 111: 161-171; discussion 172-173.
132. LOPEZ-CASAS, P.P., MIZRAK, S.C., LOPEZ-FERNANDEZ, L.A., PAZ, M., DE ROOIJ, D.G. and DEL MAZO, J. (2012). The effects of different endocrine disruptors defin-ing compound-specific alterations of gene expression profiles in the developing testis. Reprod Toxicol 33: 106-115.
133. LU, L., KATSAROS, D., SHAVERDASHVILI, K., QIAN, B., WU, Y., DE LA LONGRAIS, I.A., PRETI, M., MENATO, G. and YU, H. (2009). Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. Eur J Cancer 45: 2212-2218.
134. MAJUMDER, S. and JACOB, S.T. (2011). Emerging role of microRNAs in drug-resistant breast cancer. Gene Expr 15: 141-151.
135. MANTON, K.J., DOUGLAS, M.L., NETZEL-ARNETT, S., FITZPATRICK, D.R., NICOL, D.L., BOYD, A.W., CLEMENTS, J.A. and ANTALIS, T.M. (2005). Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis. Br J Cancer 92: 760-769.
136. MARTIN, G.M. (2009). Epigenetic gambling and epigenetic drift as an antagonistic pleiotropic mechanism of aging. Aging Cell 8: 761-764.
137. MATIN, A. and NADEAU, J.H. (2005). Search for testicular cancer gene hits dead-end. Cell Cycle 4: 1136-1138.
138. MCGLYNN, K.A., QURAISHI, S.M., GRAUBARD, B.I., WEBER, J.P., RUBERTONE, M.V. and ERICKSON, R.L. (2008). Persistent organochlorine pesticides and risk of testicular germ cell tumors. J Natl Cancer Inst 100: 663-671.
139. MCGLYNN, K.A., QURAISHI, S.M., GRAUBARD, B.I., WEBER, J.P., RUBERTONE, M.V. and ERICKSON, R.L. (2009). Polychlorinated biphenyls and risk of testicular germ cell tumors. Cancer Res 69: 1901-1909.
140. MCIVER, S.C., ROMAN, S.D., NIXON, B. and MCLAUGHLIN, E.A. (2012). miRNA and mammalian male germ cells. Hum Reprod Update 18: 44-59.
141. MCLAREN, A. (2003). Primordial germ cells in the mouse. Dev Biol 262: 1-15.
142. MCLAREN, A. and LAWSON, K.A. (2005). How is the mouse germ-cell lineage established? Differentiation 73: 435-437.
143. MEISSNER, A. (2010). Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 28: 1079-1088.
144. MELTON, C., JUDSON, R.L. and BLELLOCH, R. (2010). Opposing microRNA fami-lies regulate self-renewal in mouse embryonic stem cells. Nature 463: 621-626.
145. MERRITT, W.M., LIN, Y.G., HAN, L.Y., KAMAT, A.A., SPANNUTH, W.A., SCHMANDT, R., URBAUER, D., PENNACCHIO, L.A., CHENG, J.F., NICK, A.M. et al., (2008). Dicer, Drosha, and outcomes in patients with ovarian cancer. N Engl J Med 359: 2641-2650.
146. MOE-BEHRENS, G.H., KLINGER, F.G., ESKILD, W., GROTMOL, T., HAUGEN, T.B. and DE FELICI, M. (2003). Akt/PTEN signaling mediates estrogen-dependent proliferation of primordial germ cells in vitro. Mol Endocrinol 17: 2630-2638.
147. MOHAMED, G.H., GELFOND, J.A., NICOLAS, M.M., BRAND, T.C., SARVIS, J.A., LEACH, R.J. and JOHNSON-PAIS, T.L. (2012). Genomic Characterization of Testis Cancer: Association of Alterations With Outcome of Clinical Stage 1 Mixed Germ Cell Nonseminomatous Germ Cell Tumor of the Testis. Urology 80: 485.e1-485.e5
148. MOSTOFI, F.K. (1973). Proceedings: Testicular tumors. Epidemiologic, etiologic, and pathologic features. Cancer 32: 1186-1201.
149. MOTZER, R.J., AGARWAL, N., BEARD, C., BHAYANI, S., BOLGER, G.B., BUYYOU-NOUSKI, M.K., CARDUCCI, M.A., CHANG, S.S., CHOUEIRI, T.K., GUPTA, S. et al., (2012). Testicular cancer. J Natl Compr Canc Netw 10: 502-535.
150. MU, W. and ZHANG, W. (2012). Bioinformatic Resources of microRNA Sequences, Gene Targets, and Genetic Variation. Front Genet 3: 31.
151. NEGRINI, M. and CALIN, G.A. (2008). Breast cancer metastasis: a microRNA story. Breast Cancer Res 10: 203.
152. NEWMAN, M.A. and HAMMOND, S.M. (2010). Lin-28: an early embryonic sentinel that blocks Let-7 biogenesis. Int J Biochem Cell Biol 42: 1330-1333.
153. NEWMAN, M.A., THOMSON, J.M. and HAMMOND, S.M. (2008). Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14: 1539-1549.
154. NICHOLS, J., ZEVNIK, B., ANASTASSIADIS, K., NIWA, H., KLEWE-NEBENIUS, D., CHAMBERS, I., SCHOLER, H. and SMITH, A. (1998). Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95: 379-91.
155. NISHIKURA, K. (2010). Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem 79: 321-349.
156. NIWA, H. (2007). How is pluripotency determined and maintained? Development 134: 635-646.
157. OHINATA, Y., PAYER, B., O'CARROLL, D., ANCELIN, K., ONO, Y., SANO, M., BARTON, S.C., OBUKHANYCH, T., NUSSENZWEIG, M., TARAKHOVSKY, A. et al., (2005). Blimp1 is a critical determinant of the germ cell lineage in mice. Nature 436: 207-213.
158. OKADA, K., KATAGIRI, T., TSUNODA, T., MIZUTANI, Y., SUZUKI, Y., KAMADA, M., FUJIOKA, T., SHUIN, T., MIKI, T. and NAKAMURA, Y. (2003). Analysis of gene-expression profiles in testicular seminomas using a genome-wide cDNA microarray. Int J Oncol 23: 1615-1635.
159. OKAMOTO, K. and KAWAKAMI, T. (2007). Epigenetic profile of testicular germ cell tumours. Int J Androl 30: 385-392; discussion 392.
160. OOSTERHUIS, J.W. and LOOIJENGA, L.H. (2005). Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5: 210-222.
161. ORRENIUS, S. (2007). Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev 39: 443-455.
162. PALMER, R.D., MURRAY, M.J., SAINI, H.K., VAN DONGEN, S., ABREU-GOODGER, C., MURALIDHAR, B., PETT, M.R., THORNTON, C.M., NICHOLSON, J.C., EN-RIGHT, A.J. et al., (2010). Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70: 2911-2923.
163. PALUMBO, C., VAN ROOZENDAAL, K., GILLIS, A.J., VAN GURP, R.H., DE MUNN-IK, H., OOSTERHUIS, J.W., VAN ZOELEN, E.J. and LOOIJENGA, L.H. (2002). Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues. Implications for the early diagnosis of tes-ticular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol 196: 467-477.
164. PAN, L., GONG, Z., ZHONG, Z., DONG, Z., LIU, Q., LE, Y. and GUO, J. (2011). Lin-28 reactivation is required for let-7 repression and proliferation in human small cell lung cancer cells. Mol Cell Biochem 355: 257-63.
165. PARK, S.Y. and JAMESON, J.L. (2005). Minireview: transcriptional regulation of gonadal development and differentiation. Endocrinology 146: 1035-1042.
166. PARRAGA, M. and DEL MAZO, J. (2000). XYbp, a novel RING-finger protein, is a com-ponent of the XY body of spermatocytes and centrosomes. Mech Dev 90: 95-101.
167. PAYNE, A.H., HARDY, M.P. and RUSSELL, L.D. (1996). The Leydig cell. Cache River Press Vienna, IL.
168. PISKOUNOVA, E., VISWANATHAN, S.R., JANAS, M., LAPIERRE, R.J., DALEY, G.Q., SLIZ, P. and GREGORY, R.I. (2008). Determinants of microRNA process-ing inhibition by the developmentally regulated RNA-binding protein Lin28. J Biol Chem 283: 21310-21314.
169. POLANCO, J.C. and KOOPMAN, P. (2007). Sry and the hesitant beginnings of male development. Dev Biol 302: 13-24.
170. POPP, C., DEAN, W., FENG, S., COKUS, S.J., ANDREWS, S., PELLEGRINI, M., JACOBSEN, S.E. and REIK, W. (2010). Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 463: 1101-5.
171. PORTELA, A. and ESTELLER, M. (2010). Epigenetic modifications and human disease. Nat Biotechnol 28: 1057-1068.
172. RAJASETHUPATHY, P., ANTONOV, I., SHERIDAN, R., FREY, S., SANDER, C., TUS-CHL, T. and KANDEL, E.R. (2012). A Role for Neuronal piRNAs in the Epigenetic Control of Memory-Related Synaptic Plasticity. Cell 149: 693-707.
173. RAJPERT-DE MEYTS, E. (2006). Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12: 303-323.
174. RAJPERT-DE MEYTS, E., JORGENSEN, N., BRONDUM-NIELSEN, K., MULLER, J. and SKAKKEBAEK, N.E. (1998). Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 106: 198-204; discussion 204-206.
175. RAJPERT-DE MEYTS, E. and SKAKKEBAEK, N.E. (1994). Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 17: 85-92.
176. RICHBURG, J.H., JOHNSON, K.J., SCHOENFELD, H.A., MEISTRICH, M.L. and DIX, D.J. (2002). Defining the cellular and molecular mechanisms of toxicant action in the testis. Toxicol Lett 135: 167-183.
177. RICHIARDI, L., BELLOCCO, R., ADAMI, H.O., TORRANG, A., BARLOW, L., HAKU-LINEN, T., RAHU, M., STENGREVICS, A., STORM, H., TRETLI, S. et al., (2004). Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13: 2157-2166.
178. RICHIE, J.P. (2005). OCT4 staining in testicular tumors. A sensitive and specific marker for seminoma and embryonal carcinoma. J Urol 174: 569-570.
179. RO, S., PARK, C., SANDERS, K.M., MCCARREY, J.R. and YAN, W. (2007). Cloning and expression profiling of testis-expressed microRNAs. Dev Biol 311: 592-602.
180. RODRIGUEZ, S., JAFER, O., GOKER, H., SUMMERSGILL, B.M., ZAFARANA, G., GILLIS, A.J., VAN GURP, R.J., OOSTERHUIS, J.W., LU, Y.J., HUDDART, R. et al., (2003). Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene 22: 1880-1891.
181. ROSS, J.S., CARLSON, J.A. and BROCK, G. (2007). miRNA: the new gene silencer. Am J Clin Pathol 128: 830-836.
182. RUNYAN, C., SCHAIBLE, K., MOLYNEAUX, K., WANG, Z., LEVIN, L. and WYLIE, C. (2006). Steel factor controls midline cell death of primordial germ cells and is essential for their normal proliferation and migration. Development 133: 4861-4869.
183. RYBAK, A., FUCHS, H., SMIRNOVA, L., BRANDT, C., POHL, E.E., NITSCH, R. and WULCZYN, F.G. (2008). A feedback loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-cell commitment. Nat Cell Biol 10: 987-993.
184. SAITOU, M., BARTON, S.C. and SURANI, M.A. (2002). A molecular programme for the specification of germ cell fate in mice. Nature 418: 293-300.
185. SAITOU, M., PAYER, B., LANGE, U.C., ERHARDT, S., BARTON, S.C. and SURANI, M.A. (2003). Specification of germ cell fate in mice. Philos Trans R Soc Lond B Biol Sci 358: 1363-1370.
186. SANSAM, C.L., WELLS, K.S. and EMESON, R.B. (2003). Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc Natl Acad Sci USA 100: 14018-14023.
187. SATO, F., TSUCHIYA, S., MELTZER, S.J. and SHIMIZU, K. (2011). MicroRNAs and epigenetics. FEBS J 278: 1598-1609.
188. SCHILLING, E. and REHLI, M. (2007). Global, comparative analysis of tissue-specific promoter CpG methylation. Genomics 90: 314-323.
189. SCHNEIDER, D.T., SCHUSTER, A.E., FRITSCH, M.K., HU, J., OLSON, T., LAUER, S., GOBEL, U. and PERLMAN, E.J. (2001). Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors. Cancer Res 61: 7268-7276.
190. SCHNEIDER, S., KAUFMANN, W., BUESEN, R. and VAN RAVENZWAAY, B. (2008). Vinclozolin--the lack of a transgenerational effect after oral maternal exposure during organogenesis. Reprod Toxicol 25: 352-360.
191. SCHULTZ, N., HAMRA, F.K. and GARBERS, D.L. (2003). A multitude of genes ex-pressed solely in meiotic or postmeiotic spermatogenic cells offers a myriad of contraceptive targets. Proc Natl Acad Sci USA 100: 12201-12206.
192. SELBACH, M., SCHWANHAUSSER, B., THIERFELDER, N., FANG, Z., KHANIN, R. and RAJEWSKY, N. (2008). Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
193. SHARMA, S., KELLY, T.K. and JONES, P.A. (2010). Epigenetics in cancer. Carci-nogenesis 31: 27-36.
194. SHARPE, R.M., MCKINNELL, C., KIVLIN, C. and FISHER, J.S. (2003). Proliferation and functional maturation of Sertoli cells, and their relevance to disorders of testis function in adulthood. Reproduction 125: 769-784.
195. SHARPE, R.M. and SKAKKEBAEK, N.E. (1993). Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341: 1392-1395.
196. SHEIKINE, Y., GENEGA, E., MELAMED, J., LEE, P., REUTER, V.E. and YE, H. (2012). Molecular genetics of testicular germ cell tumors. Am J Cancer Res 2: 153-167.
197. SIEGEL, R., DESANTIS, C., VIRGO, K., STEIN, K., MARIOTTO, A., SMITH, T., COOPER, D., GANSLER, T., LERRO, C., FEDEWA, S. et al., (2012). Cancer treatment and survivorship statistics. CA Cancer J Clin. 62: 220-241.
198. SIEVERS, S., ALEMAZKOUR, K., ZAHN, S., PERLMAN, E.J., GILLIS, A.J., LOOI-JENGA, L.H., GOBEL, U. and SCHNEIDER, D.T. (2005). IGF2/H19 imprinting analysis of human germ cell tumors (GCTs) using the methylation-sensitive single-nucleotide primer extension method reflects the origin of GCTs in different stages of primordial germ cell development. Genes Chromosomes Cancer 44: 256-264.
199. SIKKA, S.C., RAJASEKARAN, M. and HELLSTROM, W.J. (1995). Role of oxidative stress and antioxidants in male infertility. J Androl 16: 464-468.
200. SIOMI, M.C., SATO, K., PEZIC, D. and ARAVIN, A.A. (2011). PIWI-interacting small RNAs: the vanguard of genome defence. Nat Rev Mol Cell Biol 12: 246-258.
201. SJOBLOM, T., WEST, A. and LAHDETIE, J. (1998). Apoptotic response of spermato-genic cells to the germ cell mutagens etoposide, adriamycin, and diepoxybutane. Environ Mol Mutagen 31: 133-148.
202. SKAKKEBAEK, N.E. (1972). Possible carcinoma-in-situ of the testis. Lancet 2: 516-517.
203. SKAKKEBAEK, N.E., RAJPERT-DE MEYTS, E. and MAIN, K.M. (2001). Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16: 972-978.
204. SKINNER, M.K. (2007). Epigenetic transgenerational toxicology and germ cell disease. Int J Androl 30: 393-6; discussion 396-397.
205. SKINNER, M.K. and ANWAY, M.D. (2005). Seminiferous cord formation and germ-cell programming: epigenetic transgenerational actions of endocrine disruptors. Ann N Y Acad Sci 1061: 18-32.
206. SKINNER, M.K. and GRISWOLD, M.D. (2005). Sertoli Cell Biology. Academic Press, Amsterdam.
207. SKINNER, M.K., MANIKKAM, M. and GUERRERO-BOSAGNA, C. (2011). Epigenetic transgenerational actions of endocrine disruptors. Reprod Toxicol 31: 337-343.
208. SMIRAGLIA, D.J., SZYMANSKA, J., KRAGGERUD, S.M., LOTHE, R.A., PELTOMAKI, P. and PLASS, C. (2002). Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21: 3909-3916.
209. SMITH-SORENSEN, B., LIND, G.E., SKOTHEIM, R.I., FOSSA, S.D., FODSTAD, O., STENWIG, A.E., JAKOBSEN, K.S. and LOTHE, R.A. (2002). Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer. Oncogene 21: 8878-8884.
210. SNEAD, N.M. and ROSSI, J.J. (2010). Biogenesis and function of endogenous and exogenous siRNAs. Wiley Interdiscip Rev RNA 1: 117-131.
211. SPERGER, J.M., CHEN, X., DRAPER, J.S., ANTOSIEWICZ, J.E., CHON, C.H., JONES, S.B., BROOKS, J.D., ANDREWS, P.W., BROWN, P.O. and THOMSON, J.A. (2003). Gene expression patterns in human embryonic stem cells and hu-man pluripotent germ cell tumors. Proc Natl Acad Sci USA 100: 13350-13355.
212. STEVENS, L.C. (1962). Testicular teratomas in fetal mice. J Natl Cancer Inst 28: 247-267.
213. STEVENS, L.C. (1964). Experimental Production of Testicular Teratomas in Mice. Proc Natl Acad Sci USA 52: 654-661.
214. STEVENS, L.C. (1967). Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst 38: 549-552.
215. STEVENS, L.C. (1973). A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst 50: 235-242.
216. STEVENS, L.C. (1984). Spontaneous and experimentally induced testicular teratomas in mice. Cell Differ 15: 69-74.
217. STEVENS, L.C. and HUMMEL, K.P. (1957). A description of spontaneous congenital testicular teratomas in strain 129 mice. J Natl Cancer Inst 18: 719-747.
218. STEVENS, L.C. and LITTLE, C.C. (1954). Spontaneous Testicular Teratomas in an Inbred Strain of Mice. Proc Natl Acad Sci USA 40: 1080-1087.
219. STORGAARD, L., BONDE, J.P. and OLSEN, J. (2006). Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reprod Toxicol 21: 4-15.
220. STOUDER, C. and PAOLONI-GIACOBINO, A. (2010). Transgenerational effects of the endocrine disruptor vinclozolin on the methylation pattern of imprinted genes in the mouse sperm. Reproduction 139: 373-379.
221. STROHMEYER, T., REESE, D., PRESS, M., ACKERMANN, R., HARTMANN, M. and SLAMON, D. (1995). Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153: 511-515.
222. SURANI, M.A. and HAJKOVA, P. (2010). Epigenetic reprogramming of mouse germ cells toward totipotency. Cold Spring Harb Symp Quant Biol 75: 211-218.
223. SZABO, P.E. and MANN, J.R. (1995). Biallelic expression of imprinted genes in the mouse germ line: implications for erasure, establishment, and mechanisms of genomic imprinting. Genes Dev 9: 1857-1868.
224. TESSEL, M.A., KRETT, N.L. and ROSEN, S.T. (2010). Steroid receptor and microRNA regulation in cancer. Curr Opin Oncol 22: 592-597.
225. THOMAS, D. (2010). Gene--environment-wide association studies: emerging ap-proaches. Nat Rev Genet 11: 259-272.
226. TILGHMAN, S.L., BRATTON, M.R., SEGAR, H.C., MARTIN, E.C., RHODES, L.V., LI, M., MCLACHLAN, J.A., WIESE, T.E., NEPHEW, K.P. and BUROW, M.E. (2012). Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One 7: e32754.
227. TOBI, E.W., LUMEY, L.H., TALENS, R.P., KREMER, D., PUTTER, H., STEIN, A.D., SLAGBOOM, P.E. and HEIJMANS, B.T. (2009). DNA methylation differences after exposure to prenatal famine are common and timing-and sex-specific. Hum Mol Genet 18: 4046-4053.
228. TOPPARI, J., LARSEN, J.C., CHRISTIANSEN, P., GIWERCMAN, A., GRANDJEAN, P., GUILLETTE, L.J., JR., JEGOU, B., JENSEN, T.K., JOUANNET, P., KEIDING, N. et al., (1996). Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104 Suppl 4: 741-803.
229. USHIDA, H., KAWAKAMI, T., MINAMI, K., CHANO, T., OKABE, H., OKADA, Y. and OKAMOTO, K. (2012). Methylation profile of DNA repetitive elements in human testicular germ cell tumor. Mol Carcinog. 51: 711-722.
230. UZUMCU, M., SUZUKI, H. and SKINNER, M.K. (2004). Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reprod Toxicol 18: 765-774.
231. VAN GURP, R.J., OOSTERHUIS, J.W., KALSCHEUER, V., MARIMAN, E.C. and LOOIJENGA, L.H. (1994). Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86: 1070-1075.
232. VAN IJZENDOORN, M.H., BAKERMANS-KRANENBURG, M.J., BELSKY, J., BEACH, S., BRODY, G., DODGE, K.A., GREENBERG, M., POSNER, M. and SCOTT, S. (2011). Gene-by-environment experiments: a new approach to finding the missing heritability. Nat Rev Genet 12: 881; author reply 881.
233. VIDAEFF, A.C. and SEVER, L.E. (2005). In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiologic evidence. Reprod Toxicol 20: 5-20.
234. VINCENT, S.D., DUNN, N.R., SCIAMMAS, R., SHAPIRO-SHALEF, M., DAVIS, M.M., CALAME, K., BIKOFF, E.K. and ROBERTSON, E.J. (2005). The zinc finger transcriptional repressor Blimp1/Prdm1 is dispensable for early axis formation but is required for specification of primordial germ cells in the mouse. Development 132: 1315-1325.
235. VISWANATHAN, S.R. and DALEY, G.Q. (2010). Lin28: A microRNA regulator with a macro role. Cell 140: 445-449.
236. VISWANATHAN, S.R., DALEY, G.Q. and GREGORY, R.I. (2008). Selective blockade of microRNA processing by Lin28. Science 320: 97-100.
237. VON EYBEN, F.E. (2004). Chromosomes, genes, and development of testicular germ cell tumors. Cancer Genet Cytogenet 151: 93-138.
238. VOORHOEVE, P.M., LE SAGE, C., SCHRIER, M., GILLIS, A.J., STOOP, H., NAGEL, R., LIU, Y.P., VAN DUIJSE, J., DROST, J., GRIEKSPOOR, A. et al., (2007). A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Adv Exp Med Biol 604: 17-46.
239. WADDINGTON, C.H. (1942). The epigenotype. Endeavour 1: 18.
240. WANG, H., SARTINI, B.L., MILLETTE, C.F. and KILPATRICK, D.L. (2006). A develop-mental switch in transcription factor isoforms during spermatogenesis controlled by alternative messenger RNA 3'-end formation. Biol Reprod 75: 318-323.
241. WANG, Y.C., CHEN, Y.L., YUAN, R.H., PAN, H.W., YANG, W.C., HSU, H.C. and JENG, Y.M. (2010). Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 31: 1516-1522.
242. WANG, Z., LUO, H., PAN, X., LIAO, M. and HOU, Y. (2012). A model for data analy-sis of microRNA expression in forensic body fluid identification. Forensic Sci Int Genet 6: 419-423.
243. WEBER, M., HELLMANN, I., STADLER, M.B., RAMOS, L., PAABO, S., REBHAN, M. and SCHUBELER, D. (2007). Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39: 457-466.
244. WEIDINGER, G., STEBLER, J., SLANCHEV, K., DUMSTREI, K., WISE, C., LOVELL-BADGE, R., THISSE, C., THISSE, B. and RAZ, E. (2003). dead end, a novel vertebrate germ plasm component, is required for zebrafish primordial germ cell migration and survival. Curr Biol 13: 1429-1434.
245. WEST, J.A., VISWANATHAN, S.R., YABUUCHI, A., CUNNIFF, K., TAKEUCHI, A., PARK, I.H., SERO, J.E., ZHU, H., PEREZ-ATAYDE, A., FRAZIER, A.L. et al., (2009). A role for Lin28 in primordial germ-cell development and germ-cell ma-lignancy. Nature 460: 909-913.
246. WESTERN, P. (2009). Foetal germ cells: striking the balance between pluripotency and differentiation. Int J Dev Biol 53: 393-409.
247. WESTERN, P.S., MILES, D.C., VAN DEN BERGEN, J.A., BURTON, M. and SIN-CLAIR, A.H. (2008). Dynamic regulation of mitotic arrest in fetal male germ cells. Stem Cells 26: 339-347.
248. WOHLFAHRT-VEJE, C., MAIN, K.M. and SKAKKEBAEK, N.E. (2009). Testicular dysgenesis syndrome: foetal origin of adult reproductive problems. Clin Endocrinol (Oxf) 71: 459-465.
249. WOODRUFF, T.J., CARLSON, A., SCHWARTZ, J.M. and GIUDICE, L.C. (2008). Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary. Fertil Steril 89: 281-300.
250. WU, S., ZHU, J., LI, Y., LIN, T., GAN, L., YUAN, X., XIONG, J., LIU, X., XU, M., ZHAO, D. et al., (2010). Dynamic epigenetic changes involved in testicular toxicity induced by di-2-(ethylhexyl) phthalate in mice. Basic Clin Pharmacol Toxicol 106: 118-23.
251. WYLIE, C.C. (1993). The biology of primordial germ cells. Eur Urol 23: 62-66; discussion 67.
252. YAMAGATA, K., FUJIYAMA, S., ITO, S., UEDA, T., MURATA, T., NAITOU, M., TAKEYAMA, K., MINAMI, Y., O'MALLEY, B.W. and KATO, S. (2009). Maturation of microRNA is hormonally regulated by a nuclear receptor. Mol Cell 36: 340-7.
253. YAMASAKI, S. and ANDERSON, P. (2008). Reprogramming mRNA translation during stress. Curr Opin Cell Biol 20: 222-226.
254. YAO, P.L., LIN, Y.C. and RICHBURG, J.H. (2012). Mono-(2-ethylhexyl) phthalate (MEHP) promotes invasion and migration of human testicular embryonal carci-noma cells. Biol Reprod 86: 160.
255. YEO, G., HOLSTE, D., KREIMAN, G. and BURGE, C.B. (2004). Variation in alterna-tive splicing across human tissues. Genome Biol 5: R74.
256. YEOM, Y.I., FUHRMANN, G., OVITT, C.E., BREHM, A., OHBO, K., GROSS, M., HUBNER, K. and SCHOLER, H.R. (1996). Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 122: 881-894.
257. YOUNGREN, K.K., COVENEY, D., PENG, X., BHATTACHARYA, C., SCHMIDT, L.S., NICKERSON, M.L., LAMB, B.T., DENG, J.M., BEHRINGER, R.R., CAPEL, B. et al., (2005). The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 435: 360-364.
258. YOUNGSON, N.A. and WHITELAW, E. (2008). Transgenerational epigenetic effects. Annu Rev Genomics Hum Genet 9: 233-257.
259. YU, Z., RAABE, T. and HECHT, N.B. (2005). MicroRNA Mirn122a reduces expression of the posttranscriptionally regulated germ cell transition protein 2 (Tnp2) mes-senger RNA (mRNA) by mRNA cleavage. Biol Reprod 73: 427-33.
260. ZAFARANA, G., GRYGALEWICZ, B., GILLIS, A.J., VISSERS, L.E., VAN DE VLIET, W., VAN GURP, R.J., STOOP, H., DEBIEC-RYCHTER, M., OOSTERHUIS, J.W., VAN KESSEL, A.G. et al., (2003). 12p-amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH. Oncogene 22: 7695-701.
261. ZHANG, B., PAN, X., COBB, G.P. and ANDERSON, T.A. (2007). microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
262. ZHANG, J., ZHAO, H., GAO, Y. and ZHANG, W. (2012). Secretory miRNAs as novel cancer biomarkers. Biochim Biophys Acta 1826: 32-43.
263. ZHANG, W. and DOLAN, M.E. (2010). The emerging role of microRNAs in drug responses. Curr Opin Mol Ther 12: 695-702.
264. ZHANG, X. and HO, S.M. (2011). Epigenetics meets endocrinology. J Mol Endocrinol 46: R11-32.